Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 190, Supplement 656
The Scandinavian Physiological Society's Annual Meeting
8/10/2007-8/12/2007
Oslo, Norway


INTESTINAL ELECTROLYTE TRANSPORT 2007: NEW TRANSPORTERS, REGULATORY PATHWAYS, AND THERAPEUTIC STRATEGIES."
Abstract number: 1001

Seidler1 U

1Dept. of Gastroenterology, Hannover Medical School, Germany

In the intestinal tract, transmucosal ion and fluid movement is dominated by the action of a defined set of ion transport proteins. CFTR, in conjunction with members of the SLC26 anion exchanger family, mediates electrogenic Cl- and HCO3­ secretion. NHE3, coupled to one or several of the SLC26 isoforms, mediates electroneutral NaCl absorption. Nutrient-coupled electrolyte transport mediates the bulk of postprandial fluid absorption, and in the distal colon, the epithelial Na+ channel ENaC enables a near complete removal of salt from the stool. Major breakstones in the recent past include the cloning of new intestinal ion transporters, the evolvement of new concepts for the regulation of electrolyte transport through the PDZ-domain-adapter-mediated formation of multiprotein signaling complexes, and the understanding that nutrient and ion transporters appear to work in a coordinated fashion. One example is the cloning of the intestinal members of the SLC26 gene family of anion transporters. Current investigations focus on finding out what physiological roles the different members of this gene family have in the different segments of the GI tract.

Ion transporters appear to be regulated in multiprotein complex of transport proteins, PDZ adapter proteins, anchoring proteins, the cytoskeleton, and the involved protein kinases. For the regulation of intestinal electrolyte transport, the members of the so-called NHERF family of PDZ-adapters play a pivotal role. Recently, first results in NHERF knockout mice suggest a more cell-type and signal-specific role of these adapter proteins than anticipated. This opens the potential for drug development targeted to PDZ domain interactions, which has potential in the treatment of diarrheal diseases, cystic fibrosis and other ion transport dysfunctions.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 190, Supplement 656 :1001

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE